Is CRISPR Stock Going to $95? 1 Wall Street Analyst Thinks So.
CRSPCRISPR Therapeutics(CRSP) The Motley Fool·2024-05-15 23:11

How much would you pay for a stock that might earn 25ayearinsixyears?CRISPRTherapeutics(CRSP2.2625 a year in six years? CRISPR Therapeutics (CRSP 2.26%) closed last week down 8.5% after reporting first-quarter "earnings" results that looked a lot more like losses. Lacking a big milestone payment like the one in Q1 2023, CRISPR's revenue plummeted 99.5% year over year, and the company reported a per-share loss of 1.43 -- more than twice the year-ago loss. And that's OK -- at least according to Oppenheimer analyst Jay Olson, who on Friday lowered his ...